Loading data
CRNTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 338.73 m USD | 394.19 m USD | 347.18 m USD | 295.17 m USD | 290.77 m USD |
| Cost of revenue | 224.18 m USD | 257.34 m USD | 227.31 m USD | 202.11 m USD | 202.39 m USD |
| Gross profit | 114.55 m USD | 136.85 m USD | 119.87 m USD | 93.06 m USD | 88.38 m USD |
| Research and development expense | 30.43 m USD | 34.95 m USD | 32.27 m USD | 29.69 m USD | 29.47 m USD |
| Operating profit | 7.25 m USD | 38.73 m USD | 21.21 m USD | -10.94 m USD | 4.81 m USD |
| Interest expense | 5.03 m USD | 5.97 m USD | 7.54 m USD | 5.02 m USD | 4.65 m USD |
| Profit before tax | 708 k USD | 27.25 m USD | 12.74 m USD | -17.24 m USD | -3.82 m USD |
| Income tax expense | 2.8 m USD | 3.19 m USD | 6.52 m USD | 2.45 m USD | 11.01 m USD |
| Net income (reported basis) | -2.09 m USD | 24.06 m USD | 6.22 m USD | -19.69 m USD | -14.83 m USD |
| Basic earnings per share | -0.02 USD/share | 0.28 USD/share | 0.07 USD/share | -0.23 USD/share | -0.18 USD/share |
| Diluted earnings per share | -0.02 USD/share | 0.27 USD/share | 0.07 USD/share | -0.23 USD/share | -0.18 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.